vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and CANTALOUPE, INC. (CTLP). Click either name above to swap in a different company.

CANTALOUPE, INC. is the larger business by last-quarter revenue ($78.7M vs $39.8M, roughly 2.0× Carter Bankshares, Inc.). On growth, Carter Bankshares, Inc. posted the faster year-over-year revenue change (15.4% vs 6.8%). Carter Bankshares, Inc. produced more free cash flow last quarter ($31.8M vs $-614.0K). Over the past eight quarters, Carter Bankshares, Inc.'s revenue compounded faster (9.1% CAGR vs 7.7%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

Cantaloupe, Inc., previously known as USA Technologies Inc., is an American company known for its work with ePort cashless acceptance technology running on its patented ePort Connect service, a PCI compliant services. ePort Connect wirelessly facilitates electronic payment options to consumers with credit, debit, or NFC enabled electronic wallets like Apple Pay and Google Pay while providing operators with both telemetry and machine-to-machine (M2M) services. ePort technology is primarily fou...

CARE vs CTLP — Head-to-Head

Bigger by revenue
CTLP
CTLP
2.0× larger
CTLP
$78.7M
$39.8M
CARE
Growing faster (revenue YoY)
CARE
CARE
+8.6% gap
CARE
15.4%
6.8%
CTLP
More free cash flow
CARE
CARE
$32.4M more FCF
CARE
$31.8M
$-614.0K
CTLP
Faster 2-yr revenue CAGR
CARE
CARE
Annualised
CARE
9.1%
7.7%
CTLP

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CARE
CARE
CTLP
CTLP
Revenue
$39.8M
$78.7M
Net Profit
$-70.0K
Gross Margin
Operating Margin
27.8%
2.0%
Net Margin
-0.1%
Revenue YoY
15.4%
6.8%
Net Profit YoY
-101.4%
EPS (diluted)
$0.38
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
CTLP
CTLP
Q4 25
$39.8M
$78.7M
Q3 25
$39.1M
$80.9M
Q2 25
$37.3M
$82.6M
Q1 25
$37.0M
$75.4M
Q4 24
$34.5M
$73.7M
Q3 24
$34.2M
$70.8M
Q2 24
$33.6M
$72.7M
Q1 24
$33.5M
$67.9M
Net Profit
CARE
CARE
CTLP
CTLP
Q4 25
$-70.0K
Q3 25
$5.4M
$-919.0K
Q2 25
$8.5M
$6.8M
Q1 25
$9.0M
$49.2M
Q4 24
$5.0M
Q3 24
$5.6M
$3.6M
Q2 24
$4.8M
$2.2M
Q1 24
$5.8M
$4.7M
Gross Margin
CARE
CARE
CTLP
CTLP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
39.6%
Operating Margin
CARE
CARE
CTLP
CTLP
Q4 25
27.8%
2.0%
Q3 25
18.3%
2.0%
Q2 25
28.5%
6.3%
Q1 25
30.1%
9.1%
Q4 24
31.0%
8.4%
Q3 24
20.5%
5.8%
Q2 24
17.6%
4.9%
Q1 24
21.6%
6.3%
Net Margin
CARE
CARE
CTLP
CTLP
Q4 25
-0.1%
Q3 25
13.9%
-1.1%
Q2 25
22.8%
8.3%
Q1 25
24.2%
65.2%
Q4 24
6.7%
Q3 24
16.4%
5.0%
Q2 24
14.3%
3.0%
Q1 24
17.4%
6.9%
EPS (diluted)
CARE
CARE
CTLP
CTLP
Q4 25
$0.38
$0.00
Q3 25
$0.24
$-0.02
Q2 25
$0.37
$0.10
Q1 25
$0.39
$0.65
Q4 24
$0.36
$0.07
Q3 24
$0.24
$0.04
Q2 24
$0.21
$0.03
Q1 24
$0.25
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
CTLP
CTLP
Cash + ST InvestmentsLiquidity on hand
$53.0M
Total DebtLower is stronger
$37.7M
Stockholders' EquityBook value
$419.7M
$252.5M
Total Assets
$4.9B
$381.9M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CARE
CARE
CTLP
CTLP
Q4 25
$53.0M
Q3 25
$55.0M
Q2 25
$51.1M
Q1 25
$46.3M
Q4 24
$27.7M
Q3 24
$33.1M
Q2 24
$58.9M
Q1 24
$50.2M
Total Debt
CARE
CARE
CTLP
CTLP
Q4 25
$37.7M
Q3 25
$38.3M
Q2 25
$38.7M
Q1 25
$39.2M
Q4 24
$37.0M
Q3 24
$37.3M
Q2 24
$37.5M
Q1 24
$38.1M
Stockholders' Equity
CARE
CARE
CTLP
CTLP
Q4 25
$419.7M
$252.5M
Q3 25
$412.8M
$251.8M
Q2 25
$405.6M
$251.0M
Q1 25
$401.8M
$240.7M
Q4 24
$384.3M
$190.1M
Q3 24
$386.8M
$186.2M
Q2 24
$364.4M
$181.7M
Q1 24
$359.1M
$178.8M
Total Assets
CARE
CARE
CTLP
CTLP
Q4 25
$4.9B
$381.9M
Q3 25
$4.8B
$389.5M
Q2 25
$4.8B
$381.9M
Q1 25
$4.7B
$370.5M
Q4 24
$4.7B
$303.0M
Q3 24
$4.6B
$312.1M
Q2 24
$4.5B
$335.6M
Q1 24
$4.6B
$319.9M
Debt / Equity
CARE
CARE
CTLP
CTLP
Q4 25
0.15×
Q3 25
0.15×
Q2 25
0.15×
Q1 25
0.16×
Q4 24
0.19×
Q3 24
0.20×
Q2 24
0.21×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
CTLP
CTLP
Operating Cash FlowLast quarter
$39.9M
$3.1M
Free Cash FlowOCF − Capex
$31.8M
$-614.0K
FCF MarginFCF / Revenue
79.9%
-0.8%
Capex IntensityCapex / Revenue
20.2%
4.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$54.6M
$25.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
CTLP
CTLP
Q4 25
$39.9M
$3.1M
Q3 25
$11.8M
$7.0M
Q2 25
$9.6M
$9.4M
Q1 25
$6.4M
$22.4M
Q4 24
$36.9M
$522.0K
Q3 24
$10.3M
$-12.0M
Q2 24
$-2.5M
$14.3M
Q1 24
$17.6M
$14.7M
Free Cash Flow
CARE
CARE
CTLP
CTLP
Q4 25
$31.8M
$-614.0K
Q3 25
$10.3M
$3.5M
Q2 25
$7.7M
$4.3M
Q1 25
$4.9M
$18.6M
Q4 24
$28.8M
$-3.8M
Q3 24
$8.4M
$-15.8M
Q2 24
$-4.3M
$8.5M
Q1 24
$16.3M
$11.4M
FCF Margin
CARE
CARE
CTLP
CTLP
Q4 25
79.9%
-0.8%
Q3 25
26.3%
4.4%
Q2 25
20.6%
5.3%
Q1 25
13.1%
24.6%
Q4 24
83.5%
-5.1%
Q3 24
24.6%
-22.3%
Q2 24
-12.7%
11.7%
Q1 24
48.8%
16.9%
Capex Intensity
CARE
CARE
CTLP
CTLP
Q4 25
20.2%
4.8%
Q3 25
3.9%
4.2%
Q2 25
5.1%
6.2%
Q1 25
4.1%
5.1%
Q4 24
23.6%
5.8%
Q3 24
5.5%
5.4%
Q2 24
5.4%
7.9%
Q1 24
3.9%
4.8%
Cash Conversion
CARE
CARE
CTLP
CTLP
Q4 25
Q3 25
2.18×
Q2 25
1.13×
1.38×
Q1 25
0.71×
0.46×
Q4 24
0.10×
Q3 24
1.83×
-3.36×
Q2 24
-0.51×
6.47×
Q1 24
3.03×
3.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CARE
CARE

Segment breakdown not available.

CTLP
CTLP

Transaction Processing$47.9M61%
Subscription Revenue$21.8M28%
Products$9.0M11%

Related Comparisons